#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Follicular lymphoma Thymic carcinoma Crohn's disease Glomerulonephritis rapidly progressive Liposarcoma Thrombocytosis Neuroendocrine tumour of the lung Pleural mesothelioma Lymphatic malformation Gastric cancer White matter lesion Focal segmental glomerulosclerosis Essential thrombocythaemia Small cell lung cancer recurrent Burkitt's lymphoma More trials…

    Learn about Rare Diseases

    Familial haemophagocytic lymphohistiocytosis – Life with Disease Mucopolysaccharidosis II – Basic Information Ewing’s sarcoma recurrent – Treatment Soft tissue sarcoma – Diagnostics Focal segmental glomerulosclerosis – Life with Disease Angiosarcoma non-metastatic – Diagnostics Glomerulonephritis membranoproliferative – Treatment Systemic sclerosis pulmonary – Trials in Disease Von Willebrand’s disease Turner’s syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mecillinam Etoposide Phosphate Necvax-Neo1 Sar441566 Repagermanium CITRIC ACID ANHYDROUS CLESROVIMAB Cocarboxylase Tetrahydrate Histidine Saline POLYMYXIN B SULFATE Buloxibutid Regn7257 Romiplostim AUR200 Treprostinil Sodium Camonsertib Evg321 Cabergoline Gelatin More therapies…

    Learn about Your Condition

    Trisomy 21 Dermatitis atopic Chronic hepatic failure Hypoparathyroidism Head and neck cancer Lichen planopilaris Diabetic autonomic neuropathy Thrombocytosis Menopausal symptoms Measles Haemolytic uraemic syndrome Arteriovenous graft thrombosis Gestational diabetes Hyperkalaemia Lymphangiosarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Extragonadal primary germ cell tumour

  • A study to evaluate the safety of SGN-ALPV in patients with advanced solid tumors

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Testicular germ cell cancer
    • Cervix carcinoma
    • Ovarian cancer
    Investigated Drugs:
    • SGN-ALPV
    Denmark The Netherlands Spain Sweden

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!